TY  - GEN
AU  - Takenaka,T
AU  - Shirakawa,S
AU  - Mikuni,C
AU  - Sai,T
AU  - Shimamoto,Y
AU  - Araki,K
AU  - Hirano,M
AU  - Miura,A
AU  - Ohno,Y
AU  - Ichimaru,M
AU  - Hanada,S
AU  - Inaba,S
AU  - Konishi,H
AU  - Toki,H
AU  - Tajima,K
AU  - Niimi,M
AU  - Fukuda,H
AU  - Shimoyama,M
TI  - Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group
SN  - 0368-2811
PY  - 2000///0127
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Drug Evaluation
KW  - Female
KW  - Humans
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Prednisone
KW  - Survival Rate
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jjco/29.10.485
ER  -